Cargando…

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators

Clinical studies with modulators of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein have demonstrated that functional restoration of the mutated CFTR can lead to substantial clinical benefit. However, studies have shown highly variable patient responses. The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pranke, Iwona M., Hatton, Aurélie, Simonin, Juliette, Jais, Jean Philippe, Le Pimpec-Barthes, Françoise, Carsin, Ania, Bonnette, Pierre, Fayon, Michael, Stremler-Le Bel, Nathalie, Grenet, Dominique, Thumerel, Matthieu, Mazenq, Julie, Urbach, Valerie, Mesbahi, Myriam, Girodon-Boulandet, Emanuelle, Hinzpeter, Alexandre, Edelman, Aleksander, Sermet-Gaudelus, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547155/
https://www.ncbi.nlm.nih.gov/pubmed/28785019
http://dx.doi.org/10.1038/s41598-017-07504-1
_version_ 1783255664824418304
author Pranke, Iwona M.
Hatton, Aurélie
Simonin, Juliette
Jais, Jean Philippe
Le Pimpec-Barthes, Françoise
Carsin, Ania
Bonnette, Pierre
Fayon, Michael
Stremler-Le Bel, Nathalie
Grenet, Dominique
Thumerel, Matthieu
Mazenq, Julie
Urbach, Valerie
Mesbahi, Myriam
Girodon-Boulandet, Emanuelle
Hinzpeter, Alexandre
Edelman, Aleksander
Sermet-Gaudelus, Isabelle
author_facet Pranke, Iwona M.
Hatton, Aurélie
Simonin, Juliette
Jais, Jean Philippe
Le Pimpec-Barthes, Françoise
Carsin, Ania
Bonnette, Pierre
Fayon, Michael
Stremler-Le Bel, Nathalie
Grenet, Dominique
Thumerel, Matthieu
Mazenq, Julie
Urbach, Valerie
Mesbahi, Myriam
Girodon-Boulandet, Emanuelle
Hinzpeter, Alexandre
Edelman, Aleksander
Sermet-Gaudelus, Isabelle
author_sort Pranke, Iwona M.
collection PubMed
description Clinical studies with modulators of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein have demonstrated that functional restoration of the mutated CFTR can lead to substantial clinical benefit. However, studies have shown highly variable patient responses. The objective of this study was to determine a biomarker predictive of the clinical response. CFTR function was assessed in vivo via nasal potential difference (NPD) and in human nasal epithelial (HNE) cultures by the response to Forskolin/IBMX and the CFTR potentiator VX-770 in short-circuit-current (∆I(scF/I+V)) experiments. CFTR expression was evaluated by apical membrane fluorescence semi-quantification. I(sc) measurements discriminated CFTR function between controls, healthy heterozygotes, patients homozygous for the severe F508del mutation and patients with genotypes leading to absent or residual function. ∆I(scF/I+V) correlated with CFTR cellular apical expression and NPD measurements. The CFTR correctors lumacaftor and tezacaftor significantly increased the ∆I(scF/I+V) response to about 25% (SEM = 4.4) of the WT-CFTR level and the CFTR apical expression to about 22% (SEM = 4.6) of the WT-CFTR level in F508del/F508del HNE cells. The level of CFTR correction in HNE cultures significantly correlated with the FEV(1) change at 6 months in 8 patients treated with CFTR modulators. We provide the first evidence that correction of CFTR function in HNE cell cultures can predict respiratory improvement by CFTR modulators.
format Online
Article
Text
id pubmed-5547155
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55471552017-08-09 Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators Pranke, Iwona M. Hatton, Aurélie Simonin, Juliette Jais, Jean Philippe Le Pimpec-Barthes, Françoise Carsin, Ania Bonnette, Pierre Fayon, Michael Stremler-Le Bel, Nathalie Grenet, Dominique Thumerel, Matthieu Mazenq, Julie Urbach, Valerie Mesbahi, Myriam Girodon-Boulandet, Emanuelle Hinzpeter, Alexandre Edelman, Aleksander Sermet-Gaudelus, Isabelle Sci Rep Article Clinical studies with modulators of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein have demonstrated that functional restoration of the mutated CFTR can lead to substantial clinical benefit. However, studies have shown highly variable patient responses. The objective of this study was to determine a biomarker predictive of the clinical response. CFTR function was assessed in vivo via nasal potential difference (NPD) and in human nasal epithelial (HNE) cultures by the response to Forskolin/IBMX and the CFTR potentiator VX-770 in short-circuit-current (∆I(scF/I+V)) experiments. CFTR expression was evaluated by apical membrane fluorescence semi-quantification. I(sc) measurements discriminated CFTR function between controls, healthy heterozygotes, patients homozygous for the severe F508del mutation and patients with genotypes leading to absent or residual function. ∆I(scF/I+V) correlated with CFTR cellular apical expression and NPD measurements. The CFTR correctors lumacaftor and tezacaftor significantly increased the ∆I(scF/I+V) response to about 25% (SEM = 4.4) of the WT-CFTR level and the CFTR apical expression to about 22% (SEM = 4.6) of the WT-CFTR level in F508del/F508del HNE cells. The level of CFTR correction in HNE cultures significantly correlated with the FEV(1) change at 6 months in 8 patients treated with CFTR modulators. We provide the first evidence that correction of CFTR function in HNE cell cultures can predict respiratory improvement by CFTR modulators. Nature Publishing Group UK 2017-08-07 /pmc/articles/PMC5547155/ /pubmed/28785019 http://dx.doi.org/10.1038/s41598-017-07504-1 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Pranke, Iwona M.
Hatton, Aurélie
Simonin, Juliette
Jais, Jean Philippe
Le Pimpec-Barthes, Françoise
Carsin, Ania
Bonnette, Pierre
Fayon, Michael
Stremler-Le Bel, Nathalie
Grenet, Dominique
Thumerel, Matthieu
Mazenq, Julie
Urbach, Valerie
Mesbahi, Myriam
Girodon-Boulandet, Emanuelle
Hinzpeter, Alexandre
Edelman, Aleksander
Sermet-Gaudelus, Isabelle
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title_full Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title_fullStr Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title_full_unstemmed Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title_short Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
title_sort correction of cftr function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by cftr modulators
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547155/
https://www.ncbi.nlm.nih.gov/pubmed/28785019
http://dx.doi.org/10.1038/s41598-017-07504-1
work_keys_str_mv AT prankeiwonam correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT hattonaurelie correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT simoninjuliette correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT jaisjeanphilippe correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT lepimpecbarthesfrancoise correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT carsinania correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT bonnettepierre correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT fayonmichael correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT stremlerlebelnathalie correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT grenetdominique correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT thumerelmatthieu correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT mazenqjulie correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT urbachvalerie correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT mesbahimyriam correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT girodonboulandetemanuelle correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT hinzpeteralexandre correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT edelmanaleksander correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators
AT sermetgaudelusisabelle correctionofcftrfunctioninnasalepithelialcellsfromcysticfibrosispatientspredictsimprovementofrespiratoryfunctionbycftrmodulators